[go: up one dir, main page]

DE60023296D1 - Verfahren zur herstellung von 2-amino-4(4-fluorphenyl)-6-alkylpyrimidin-5-carbonsäureester - Google Patents

Verfahren zur herstellung von 2-amino-4(4-fluorphenyl)-6-alkylpyrimidin-5-carbonsäureester

Info

Publication number
DE60023296D1
DE60023296D1 DE60023296T DE60023296T DE60023296D1 DE 60023296 D1 DE60023296 D1 DE 60023296D1 DE 60023296 T DE60023296 T DE 60023296T DE 60023296 T DE60023296 T DE 60023296T DE 60023296 D1 DE60023296 D1 DE 60023296D1
Authority
DE
Germany
Prior art keywords
sup
amino
preparation
carboxylic acid
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60023296T
Other languages
English (en)
Other versions
DE60023296T2 (de
Inventor
Ulrich Veith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza AG
Original Assignee
Lonza AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza AG filed Critical Lonza AG
Application granted granted Critical
Publication of DE60023296D1 publication Critical patent/DE60023296D1/de
Publication of DE60023296T2 publication Critical patent/DE60023296T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60023296T 1999-07-13 2000-06-30 Verfahren zur herstellung von 2-amino-4(4-fluorphenyl)-6-alkylpyrimidin-5-carbonsäureester Expired - Lifetime DE60023296T2 (de)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
EP99113711 1999-07-13
EP99113711 1999-07-13
EP99120417 1999-10-14
EP99120417 1999-10-14
US18537100P 2000-02-28 2000-02-28
US18546500P 2000-02-28 2000-02-28
US185371P 2000-02-28
US185465P 2000-02-28
EP00106303 2000-03-23
EP00106303 2000-03-23
PCT/EP2000/006099 WO2001004100A1 (en) 1999-07-13 2000-06-30 Process for preparing 2-amino-4-(4-fluorphenyl)-6-alkylpyrimidine-5-carboxylate

Publications (2)

Publication Number Publication Date
DE60023296D1 true DE60023296D1 (de) 2006-03-02
DE60023296T2 DE60023296T2 (de) 2006-07-20

Family

ID=27513029

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60023296T Expired - Lifetime DE60023296T2 (de) 1999-07-13 2000-06-30 Verfahren zur herstellung von 2-amino-4(4-fluorphenyl)-6-alkylpyrimidin-5-carbonsäureester

Country Status (17)

Country Link
US (3) US6579984B1 (de)
EP (1) EP1194414B1 (de)
JP (1) JP4649813B2 (de)
KR (1) KR100649927B1 (de)
CN (1) CN1164577C (de)
AT (1) ATE307120T1 (de)
AU (1) AU6266600A (de)
CA (1) CA2378782C (de)
CZ (1) CZ304307B6 (de)
DE (1) DE60023296T2 (de)
ES (1) ES2251392T3 (de)
HK (1) HK1046682B (de)
HU (1) HU228303B1 (de)
NO (2) NO328103B1 (de)
PL (1) PL211797B1 (de)
SK (1) SK285993B6 (de)
WO (1) WO2001004100A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003305D0 (en) * 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
SI1417180T1 (sl) * 2001-07-13 2007-04-30 Astrazeneca Uk Ltd Priprava aminopirimidinskih spojin
RU2301801C2 (ru) * 2001-07-13 2007-06-27 АстраЗенека Ю-Кей Лимитед Способ получения сульфониламинопиримидиновых соединений (варианты), промежуточные продукты и способы их получения
GB0218781D0 (en) * 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
PT1578731E (pt) 2002-12-16 2010-01-12 Astrazeneca Uk Ltd Processo para a preparação de compostos pirimidina
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
EP2423195A1 (de) 2010-07-26 2012-02-29 LEK Pharmaceuticals d.d. Verfahren zur Herstellung von wesentlichen Zwischenstufen zur Synthese von Rosuvastatin oder pharmazeutisch annehmbaren Salzen davon
EP2605652B1 (de) 2010-08-18 2017-11-08 Samumed, LLC Diketone und hydroxyketone as cateninsignalweg-aktivatoren
MA38421A1 (fr) 2013-02-22 2017-03-31 Samumed Llc Gamma-dicétones en tant qu'activateurs de la voie de signalisation wnt/?-caténine
CN103910644B (zh) * 2014-04-21 2015-06-24 广西师范大学 β-烯胺酮酯类化合物及其合成方法和应用
PT3206686T (pt) 2014-08-20 2020-01-06 Samumed Llc Gama-dicetonas para o tratamento e prevenção de rugas e do envelhecimento da pele
CN110483341A (zh) * 2019-07-23 2019-11-22 上海药明康德新药开发有限公司 一种1-氰基-n-甲基甲磺酰胺的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013706A (en) * 1973-11-14 1977-03-22 Sucreries Du Soissonnais Et Compagnie Sucriere Derivatives of substituted urea, acyl ureas, and sulphonyl ureas, and a process for producing the same
DE3717815A1 (de) * 1987-05-27 1988-12-15 Bayer Ag Fungizide mittel auf basis von substituierten cyanamiden
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
JP3197971B2 (ja) * 1993-03-01 2001-08-13 塩野義製薬株式会社 ５−カルボアルコキシピリミジン誘導体の合成方法

Also Published As

Publication number Publication date
EP1194414B1 (de) 2005-10-19
DE60023296T2 (de) 2006-07-20
HK1046682A1 (en) 2003-01-24
US20040181065A1 (en) 2004-09-16
CA2378782C (en) 2009-11-10
AU6266600A (en) 2001-01-30
NO334937B1 (no) 2014-07-21
HK1046682B (zh) 2005-04-08
KR100649927B1 (ko) 2006-11-27
PL211797B1 (pl) 2012-06-29
HUP0202006A3 (en) 2003-02-28
US6579984B1 (en) 2003-06-17
NO20020163D0 (no) 2002-01-11
HU228303B1 (hu) 2013-03-28
CN1370151A (zh) 2002-09-18
ES2251392T3 (es) 2006-05-01
WO2001004100A1 (en) 2001-01-18
ATE307120T1 (de) 2005-11-15
SK222002A3 (en) 2002-06-04
NO20020163L (no) 2002-01-11
HUP0202006A2 (hu) 2002-12-28
US6984757B2 (en) 2006-01-10
US20030199695A1 (en) 2003-10-23
EP1194414A1 (de) 2002-04-10
PL353058A1 (en) 2003-10-06
US6710178B2 (en) 2004-03-23
KR20020012007A (ko) 2002-02-09
NO20092393L (no) 2002-01-11
JP2003504359A (ja) 2003-02-04
NO328103B1 (no) 2009-12-07
SK285993B6 (sk) 2008-01-07
CN1164577C (zh) 2004-09-01
CZ200261A3 (cs) 2002-05-15
CA2378782A1 (en) 2001-01-18
CZ304307B6 (cs) 2014-02-26
JP4649813B2 (ja) 2011-03-16

Similar Documents

Publication Publication Date Title
DE60023296D1 (de) Verfahren zur herstellung von 2-amino-4(4-fluorphenyl)-6-alkylpyrimidin-5-carbonsäureester
DE60002793D1 (de) Verfahren zur Herstellung von Acrolein und Acrylsäure
DE69904405D1 (de) Verfahren zur Herstellung von Essigsäure
DE69801797D1 (de) Verfahren zur Herstellung von Acrylsäure
DE60110497D1 (de) Verfahren zur Herstellung von Acrylsäure
DE60108184D1 (de) Verfahren zur Herstellung von Fettsäureestern
DE69702354D1 (de) Verfahren zur Herstellung von Acrylsäure
ATE313642T1 (de) Nukleinsäure enthaltende zusammensetzung, herstellung und verwendung
DE60005870D1 (de) Verfahren zur Herstellung von Acrylsäure
DE60207328D1 (de) Verfahren zur Herstellung von Phosphorsäureestern
DE60017237D1 (de) Verfahren zur mikrobiellen Herstellung von Polyestern
EP1185622A4 (de) Verfahren zur Herstellung von pankreatischen Inselzellen
DE60229194D1 (de) Verfahren zur Herstellung von Acrylsäure
DE69909181D1 (de) Verfahren zur Herstellung von Acrolein und Acrylsäure
DE60008830D1 (de) Verfahren zur Herstellung von keramischen Zusammensetzungen
DE69925992D1 (de) VERFAHREN ZUR HERSTELLUNG VON 5-HYDROXYBENZO[b]THIOPHEN-3-CARBONSÄURE
DE69920568D1 (de) Verfahren zur Herstellung von optisch aktivem 4-Halo-3-hydroxybuttersäureester
DE60019606D1 (de) Verfahren zur herstellung von substituierten pyrimidinen
DE69907607D1 (de) Verfahren zur Herstellung von Essigsäure
DE59704450D1 (de) Verfahren zur herstellung von 2-(2-methylphenyl)-3-methoxyacrylsäure-methylester
WO2000061729A3 (en) Regulation of the expression of transcriptional repressor genes using nucleic acid molecules
DE59810863D1 (de) Verfahren zur Herstellung von 4-(4-(4-(Hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha-dimenthylphenylessigsäure und phosphorylierter Derivate
DE60204681D1 (de) Verfahren zur herstellung von 2-[4-(2,2,-dihalocyclopropyl)phenoxy]-alkansäuren und ihre estern
DE60043559D1 (de) Verfahren zur Herstellung von Elektroden
ATE248141T1 (de) Verfahren zur herstellung von (r) und (s)- aminocarnitin und deren derivative aus d- und l- aspargin säure

Legal Events

Date Code Title Description
8364 No opposition during term of opposition